altona Diagnostics is part of the Viromarkers project, a European research initiative dedicated to advancing virus-related biomarkers for the management of chronic infections.

The FlexStar^® FLU H5N1 RT-PCR Detection Mix 1.5 RUO is available now. It is a reagent system, based on real-time PCR technology for the qualitative detection of influenza A (H5N1) virus specific RNA. The kit is for research use only (RUO).

We are proud to announce the launch of the AltoStar^® CMV PCR Kit 1.5 CAN, the first Class III-assay of altona Diagnostics that is licensed with Health Canada (HC).

In January 2025, it was time for our annual altona Diagnostics kickoff! Around 300 altona employees from our Hamburg headquarters and all 9 subsidiaries met for a packed program. Take a look at the photo gallery!

In the fall of 2024, altona Diagnostics received the certificate for compliance with all applicable requirements of the 𝘐𝘯 𝘝𝘪𝘵𝘳𝘰 Diagnostic Medical Devices Regulation (IVDR; EU 2017/746) for their PCR testing products.

December 1 is World AIDS Day. With the AltoStar^® HIV RT-PCR Kit 1.5, altona provides an CE-marked RT-PCR test to detect and quantify the human immunodeficiency virus type 1 (HIV-1) specific RNA (groups M, N and O) in human EDTA plasma.